TAMPA, Fla., Feb. 15, 2018 -- Foresight Medical, LLC, a leading provider of surgical and implant cost-containment services, today announced ForeSight and Encompass applications have earned Certified status for information security by HITRUST.
HITRUST CSF Certified status demonstrates that the organization’s ForeSight and Encompass applications have met key regulations and industry-defined requirements and is appropriately managing risk. This achievement places ForeSight Medical, LLC in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards and frameworks, and incorporating a risk-based approach, the HITRUST CSF helps organizations address these challenges through a comprehensive and flexible framework of prescriptive and scalable security controls.
“Achieving HITRUST CSF Certification is a great accomplishment for ForeSight Medical and demonstrates ForeSight Medical’s and Encompass Specialty Surgical Network’s applications maintain the security, confidentiality and integrity of our client’s data,” said Alisa Lewis, Director of Regulatory Compliance. “The HITRUST CSF is the gold-standard that needs to be met, and we are pleased to be able to show our commitment by achieving HITRUST CSF Certification.”
“As we have earned recognition for compliance in HIPAA, Hi-Tech, ISO 27001, SOC 2, and now HITRUST, there is no doubt that ForeSight’s dedication to the integrity and confidentiality of our systems is deeply ingrained in our company culture,” said Bill Elliott, Chief Operating Officer.
“The HITRUST CSF has become the information protection framework for the healthcare industry, and the CSF Assurance program is bringing a new level of effectiveness and efficiency to third-party assurance,” said Ken Vander Wal, Chief Compliance Officer, HITRUST. “The HITRUST CSF Certification is now the benchmark that organizations required to safeguard PHI are measured against with regards to information protection.”
About ForeSight Medical, LLC
ForeSight Medical is built on the idea that delivering better outcomes, quality care and administrative ease requires a profound understanding of the unique nuances surrounding surgeons, site of care dynamics, the implantable device supply chain and widely variable provider reimbursement practices. ForeSight Medical, a surgical and implantable device management organization, does just that – propelled by a team that draws on significant firsthand experience in the Ambulatory Surgical Center and Implantable Device industry. ForeSight delivers impactful results and enhances patient satisfaction through the use of mined surgical data and actionable analytics, cost containment strategies, and a true appreciation for the intricate and intersecting worlds of the medical community and Workers’ Compensation payers.
ForeSight Medical, LLC Media Contact:
Alisa Lewis
ForeSight Medical, LLC
[email protected]


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 



